A Multicentre Clinical Test of the Ultracore Repose® Mattress to Prevent Pressure Ulcers Cat. II-IV in Nursing Homes
1 other identifier
interventional
40
1 country
5
Brief Summary
A mixed method desgin study will be conducted to study pressure ulcer incidence Cat. II-IV (including deep- tissue injury,unstageable), not associated with the use of medical devices, on the Ultracore Repose® mattress (Frontier therapeutics Ltd) and to study differences in caretakers' experiences and perceptions when using the Ultracore Repose® mattress versus the Repose overlay mattress®
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2020
Shorter than P25 for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 15, 2020
CompletedFirst Submitted
Initial submission to the registry
November 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 5, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 5, 2020
CompletedFirst Posted
Study publicly available on registry
November 12, 2020
CompletedNovember 18, 2020
November 1, 2020
9 months
November 5, 2020
November 16, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence rate of pressure ulcers Cat. II-IV
Incidence rate of pressure ulcers Cat. II-IV (including deep- tissue injury, unstageable), not associated with the use of medical devices
14 days
Secondary Outcomes (1)
caretakers' experiences and perceptions
7 days
Study Arms (1)
residents
EXPERIMENTALdaily care of 40 residents will be provided on the Ultracore Repose® mattress
Interventions
residents will be placed on the Ultracore Repose® mattress for the daily care during 14 days
Three focus groups will be set- up at the end of the study to provide insights into how caregivers think about the product and to provide a deeper understanding of the difference between the use of the Ultracore Repose® mattress (versus the Repose overlay mattress® and an alternating air mattress)
Eligibility Criteria
You may qualify if:
- High risk of pressure ulcers (Braden score \< 12) and/or pressure ulcer category 1
- Bedbound (\> 8 hours in bed) or chair bound (\> 8 hours in chair)
- Aged \> 65 years
You may not qualify if:
- Pressure ulcer Category II-IV, deep tissue injury (DTI) or unstageable pressure ulcer
- Expected length of stay \< 2 weeks
- End of life care
- Medical contraindication for use of static air support devices
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Ghentlead
Study Sites (5)
Bocasa
Heusden-Zolder, Limburg, 3550, Belgium
Residentie Kartuizerhof - Vulpia
Lierde, Oost-Vlaanderen, 9572, Belgium
Woonzorgcentrum Heilig Hart
Oudenaarde, Oost-Vlaanderen, Belgium
Woonzorgcentrum Egmont
Zottegem, Oost-Vlaanderen, Belgium
Huize Zonnelied
Ieper, West-Vlaanderen, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dimitri Beeckman
University Ghent
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 5, 2020
First Posted
November 12, 2020
Study Start
February 15, 2020
Primary Completion
November 5, 2020
Study Completion
November 5, 2020
Last Updated
November 18, 2020
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- SAP, CSR
- Time Frame
- on request
data will be available upon request